Document is current
Any future updates will be listed below
-
Authors
Nagino, Ken https://orcid.org/0000-0002-0317-6074
Inomata, Takenori https://orcid.org/0000-0003-3435-1055
Nakamura, Masahiro
Sung, Jaemyoung
Midorikawa-Inomata, Akie
Iwagami, Masao
Fujio, Kenta
Akasaki, Yasutsugu
Okumura, Yuichi
Huang, Tianxiang
Fujimoto, Keiichi
Eguchi, Atsuko
Miura, Maria
Hurramhon, Shokirova
Zhu, Jun
Ohno, Mizu
Hirosawa, Kunihiko
Morooka, Yuki
Dana, Reza https://orcid.org/0000-0002-5732-5100
Murakami, Akira https://orcid.org/0000-0002-0022-2514
Kobayashi, Hiroyuki
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (20KK0207, 21K17311, 21K20998)
- License Information
-
More Information
Article History
Received: 10 January 2023
Revised: 31 March 2023
Accepted: 6 April 2023
First Online: 15 April 2023
Competing interests
: The DryEyeRhythm app was created using Apple’s ResearchKit (Cupertino, CA, USA) along with OHAKO, Inc. (Tokyo, Japan) and Medical Logue, Inc. (Tokyo, Japan). TI and YO are the owners of InnoJin, Inc, Tokyo, Japan, for developing DryEyeRhythm. TI reported receiving grants from Johnson & Johnson Vision Care, SEED Co., Ltd, Novartis Pharma K.K., and Kowa Company, Ltd. outside the submitted work, as well as personal fees from Santen Pharmaceutical Co., Ltd., and InnoJin, Inc. The remaining authors declare no conflict of interest.
